- Type / Class
- Equity / Common Stock
- Shares outstanding
- 129,867,819
- Total 13F shares
- 127,102,311
- Share change
- +851,478
- Total reported value
- $928,960,411
- Put/Call ratio
- 25%
- Price per share
- $7.31
- Number of holders
- 269
- Value change
- -$11,861,045
- Number of buys
- 151
- Number of sells
- 101
Quarterly Holders Quick Answers
What is CUSIP 64049M209?
CUSIP 64049M209 identifies NEO - NEOGENOMICS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64049M209:
Top shareholders of NEO - NEOGENOMICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
15%
|
19,864,426
|
$188,513,400 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
14,257,116
|
$135,300,032 | — | 31 Mar 2025 | |
| First Light Asset Management, LLC |
13D/G
13F
|
Mathew P. Arens · Company |
7.6%
|
9,784,749
|
$73,287,770 | $0 | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
5.2%
|
6,718,301
|
$63,756,676 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
4.8%
|
6,165,063
|
$63,315,197 | $0 | 31 Dec 2024 | |
| Greenhouse Funds LLLP |
13D/G
13F
|
Company |
5.8%
|
7,431,147
|
$55,659,291 | $0 | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
5,089,367
|
$48,298,093 | — | 31 Mar 2025 | |
| Douglas M. van Oort |
3/4/5
|
Director |
—
mixed-class rows
|
2,708,881
mixed-class rows
|
$45,677,027 | — | 01 Aug 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
3.6%
|
4,676,622
|
$44,381,000 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
3.3%
|
4,310,205
|
$41,464,172 | — | 31 Mar 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
3%
|
3,871,964
|
$36,744,936 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3%
|
3,845,129
|
$36,490,003 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
|
Company |
2.6%
|
3,317,169
|
$34,067,326 | $0 | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2.6%
|
3,319,602
|
$31,503,039 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
3,130,397
|
$29,714,027 | — | 31 Mar 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
2.8%
|
3,566,808
|
$26,073,366 | -$24,761,251 | 30 Jun 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
1.8%
|
2,350,746
|
$22,308,580 | — | 31 Mar 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.3%
|
1,752,681
|
$16,633,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,716,720
|
$16,291,673 | — | 31 Mar 2025 | |
| Christopher M. Smith |
3/4/5
|
Chief Executive Officer |
—
mixed-class rows
|
1,312,718
mixed-class rows
|
$15,690,205 | — | 23 Feb 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,574,868
|
$14,945,497 | — | 31 Mar 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,574,777
|
$14,944,634 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,546,259
|
$14,674,009 | — | 31 Mar 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.2%
|
1,527,267
|
$14,493,762 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.1%
|
1,465,899
|
$13,911,385 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
1,377,741
|
$13,074,762 | — | 31 Mar 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.94%
|
1,216,756
|
$11,547,014 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.87%
|
1,126,896
|
$10,694,243 | — | 31 Mar 2025 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.85%
|
1,109,577
|
$10,529,885 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.66%
|
858,046
|
$8,142,857 | — | 31 Mar 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.66%
|
855,688
|
$8,120,479 | — | 31 Mar 2025 | |
| Kopp Family Office, LLC |
13F
|
Company |
0.64%
|
828,575
|
$7,863,177 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.61%
|
797,364
|
$7,566,988 | — | 31 Mar 2025 | |
| Mark Mallon |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
715,828
mixed-class rows
|
$6,768,458 | — | 01 Mar 2022 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.5%
|
654,281
|
$6,209,127 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.49%
|
639,411
|
$6,068,011 | — | 31 Mar 2025 | |
| Samjo Management, LLC |
13F
|
Company |
0.48%
|
629,080
|
$5,969,969 | — | 31 Mar 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.45%
|
585,381
|
$5,555,266 | — | 31 Mar 2025 | |
| George Cardoza |
3/4/5
|
President & COO, Lab Ops |
—
mixed-class rows
|
304,659
mixed-class rows
|
$4,857,847 | — | 01 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.38%
|
498,321
|
$4,729,067 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.38%
|
497,451
|
$4,720,810 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.36%
|
471,776
|
$4,477,153 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.33%
|
433,163
|
$4,110,717 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.32%
|
413,098
|
$3,920,300 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.31%
|
407,017
|
$3,862,591 | — | 31 Mar 2025 | |
| William Bonello |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
191,548
|
$3,522,568 | — | 28 Apr 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.28%
|
366,589
|
$3,478,903 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.27%
|
348,393
|
$3,306,250 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.27%
|
345,690
|
$3,280,598 | — | 31 Mar 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.26%
|
341,936
|
$3,244,973 | — | 31 Mar 2025 |
Institutional Holders of NEOGENOMICS INC - Common Stock (NEO) as of Q2 2025
As of 30 Jun 2025,
NEOGENOMICS INC - Common Stock (NEO) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,102,311 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Greenhouse Funds LLLP, First Light Asset Management, LLC, STATE STREET CORP, MACQUARIE GROUP LTD, DIMENSIONAL FUND ADVISORS LP, SCHRODER INVESTMENT MANAGEMENT GROUP, AMERICAN CENTURY COMPANIES INC, and MILLENNIUM MANAGEMENT LLC.
This page lists
267
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
248
Q2 2025 holders
269
Holder diff
21
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.